Clinical trial
Safety and Feasibility of Umbilical Cord Blood Cell Transplant Into Injured Spinal Cord: an Open-Labeled, Dose-Escalating Clinical Tiral
NCT01046786 is registered in ClinicalTrials.gov with China Spinal Cord Injury Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Feasibility of Umbilical Cord Blood Cell Transplant Into Injured Spinal Cord: an Open-Labeled, Dose-Escalating Clinical Tiral
- Lead sponsor
- China Spinal Cord Injury Network
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- December 31, 2013
- Enrollment
- 8 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.